Overview of the November Hemp Law Changes

The modern hemp industry was shaped by the 2018 Farm Bill. The FDA’s 2019 testimony on hemp and the 2018 Farm Bill explains that qualifying hemp was removed from the federal Controlled Substances Act definition of marijuana. The law defined hemp using a Delta-9 THC concentration of no more than 0.3% on a dry-weight basis.

The Farm Bill did not make every hemp-derived product automatically legal. It preserved FDA authority over products containing cannabis or cannabis-derived compounds, and states continued to regulate cultivation and finished products within their jurisdictions.

The Agricultural Marketing Act text compiled by GovInfo, as amended by Public Law 119-37, contains additional changes scheduled to take effect on November 12, 2026. Unless Congress amends the law before that date, the revised language will change the federal hemp definition and exclude several categories of cannabinoid products.

Current Crop Testing and the Future Definition Are Different Issues

The scheduled change is sometimes described as the first federal move toward total THC. That description is incomplete. USDA crop-compliance testing already accounts for THCA conversion when calculating total THC. The new law changes the statutory hemp definition itself and creates additional rules for intermediate and final cannabinoid products.

Key Changes in the Scheduled Language

• Total tetrahydrocannabinols: The future hemp definition expressly includes THCA when applying the 0.3% dry-weight threshold.
• Intermediate-product exclusions: Certain intermediate products above a 0.3% combined threshold would be excluded, along with products containing specified manufactured cannabinoids.
• Final-product exclusions: Certain final products containing more than 0.4 milligrams combined total per retail container of total tetrahydrocannabinols and covered similar-effect cannabinoids would be excluded.
• Manufactured cannabinoids: The exclusions address cannabinoids that cannot be produced naturally by the plant and naturally occurring cannabinoids synthesized or manufactured outside the plant.
• Industrial-hemp definition: The amended text expressly addresses stalk, fiber, non-cannabinoid stalk derivatives, qualifying seed uses, microgreens, research plants, and related planting seed.

The 0.4-milligram provision applies per retail container, not per serving. The statute describes a container as the innermost retail package in direct contact with the product, such as a jar, bottle, bag, box, packet, can, carton, or cartridge.

For a broader explanation of current limits and future definitions, read Understanding THC Limits in Hemp Products.

Important: These amendments are scheduled but not yet effective as of this article’s July 2026 review date. Federal and state laws, agency guidance, and implementation details could change.

Why Farmers May Feel the Impact First

The scheduled exclusions focus heavily on products, but the economic risk begins much earlier. Farmers have to anticipate what processors and retailers will be willing to buy after harvest.

The USDA Agricultural Marketing Service hemp program explains that producers operating under the federal program must obtain a license. Depending on the location, production may instead be authorized through an approved state or tribal plan.

Growers must also follow the sampling, testing, reporting, harvest, and recordkeeping requirements of the applicable program. State or tribal rules may add requirements beyond the federal framework.

USDA Already Tests Crops Using Total THC

The USDA hemp laboratory testing guidelines require a post-decarboxylation or similarly reliable method that accounts for the potential conversion of THCA into Delta-9 THC. The result is reported on a dry-weight basis.

This means licensed growers should already understand total-THC crop compliance. The new risk is broader: whether the harvested material will still have a viable buyer and product market under the future statutory definition.

Farmers Are Making Decisions About Future Demand

A retailer can stop placing new orders. A manufacturer may change a future formula. A farmer cannot reverse a planted field after the market changes.

Growers may need to evaluate:

• Whether current genetics will remain marketable.
• Whether buyers will still purchase the same flower or biomass.
• Whether the contract defines total-THC specifications.
• Who carries the risk if the law or buyer requirements change.
• Whether the crop has another possible buyer or end use.
• Whether fiber, grain, seed, or a non-hemp crop is economically realistic.

How the Law Intersects with the Farmer Planning Timeline

The effect of the scheduled law depends partly on where a crop is in the production cycle. A farmer evaluating the 2027 season faces different decisions from a grower already managing a 2026 crop.

Farmers with harvested or stored material should also confirm how contracts treat a legal change that occurs after production but before processing or final sale. That is a legal and contractual question, not something a general article can resolve.

Impact on Flower Growers

Flower growers may face the most direct agricultural pressure because floral hemp is valued for its cannabinoid-rich buds. Genetics, cannabinoid development, aroma, harvest timing, drying, curing, testing, and buyer specifications are all connected to the intended flower market.

High-THCA Flower Faces a Direct Problem

The scheduled definition expressly includes THCA when measuring total tetrahydrocannabinols. Flower above the future 0.3% total threshold would not meet the amended federal definition of hemp.

Growers whose business model depends on THCA-rich genetics should not assume that a low measured Delta-9 THC percentage will be enough under the future language.

CBD Flower Could Face a Less Forgiving Market

CBD is naturally produced by hemp and is not prohibited by name in the scheduled amendment. However, CBD-rich flower still contains other cannabinoids, including varying levels of THC and THCA.

CBD flower would need to satisfy the applicable total-tetrahydrocannabinol definition. The market may favor genetics with more conservative THC expression, but lower THC alone does not guarantee a profitable or high-quality crop.

Growers must balance:

• CBD production.
• Total-THC compliance.
• Flower structure and aroma.
• Disease and mold resistance.
• Regional performance.
• Buyer specifications.
• Expected yield and price.

Testing Cannot Eliminate Every Market Risk

Pre-harvest testing helps a farmer understand the crop before official sampling or harvest, but a passing internal test does not guarantee that an official sample will produce the same result. Sampling location, plant variation, timing, laboratory methods, and measurement uncertainty can affect results.

Finished flower may also be tested again by processors or retailers. Growers should know which report controls under the purchase contract and what happens if results differ.

For help understanding the reports used farther down the supply chain, read How to Read a CBD Flower Lab Report.

Some Farms May Reduce Floral Acreage

Growers without dependable buyers may reduce cannabinoid acreage until the market becomes clearer. Other farms may continue with lower-risk genetics, change production scale, move into seed or propagation work, or leave hemp entirely.

For the economics behind floral hemp’s earlier growth, read Why CBD Hemp Became More Valuable Than Fiber Hemp.

Impact on Processors and Farm Buyers

Processors and other buyers may change what they are willing to purchase. That can affect farms before the scheduled law reaches the retail level.

Biomass Specifications May Become More Conservative

Extraction facilities may request biomass with lower total THC, more predictable cannabinoid ratios, stronger batch documentation, or specifications designed for a narrower finished-product market.

Buyers may also require additional indemnification, rejection rights, testing conditions, or price adjustments in their contracts. Farmers should understand those terms before planting or delivering material.

Manufacturing Options May Narrow

The scheduled language addresses cannabinoids that cannot be produced naturally by the plant and naturally occurring cannabinoids synthesized or manufactured outside the plant. Processors working with converted or manufactured cannabinoids could therefore face more direct pressure.

Some manufacturers may focus on products with very low or nondetectable THC, but a new formulation is not automatically lawful merely because it is described as non-intoxicating. Product type, ingredients, intended use, labeling, FDA requirements, and state law still matter.

The FDA’s cannabis and cannabis-derived product overview explains that FDA retains authority over covered products containing cannabis or cannabis-derived compounds.

Documentation May Become More Important

Processors and buyers may need stronger records connecting incoming biomass, extraction batches, intermediate materials, formulations, final products, labels, and laboratory reports. Farmers may be asked to provide more detailed production and testing documentation as part of that chain.

Impact on Retailers

Retailers are the most visible part of the supply chain, but their inventory decisions can move backward to manufacturers, processors, and farms. If retailers reduce or cancel future orders, growers may lose a buyer even when the crop itself passed applicable production testing.

Product Categories May Need Review

Retailers may need to review flower, gummies, oils, tinctures, vapes, extracts, topicals, and other cannabinoid products for:

• Total cannabinoid content.
• THCA and THC measurements.
• Manufacturing methods.
• Package and container size.
• Batch-specific COAs.
• State restrictions.
• FDA requirements.
• Marketing and labeling claims.

Relabeling alone would not make an excluded product meet the future hemp definition. Reformulation, repackaging, removal, or another lawful pathway may be necessary depending on the product and final implementation.

Full-Spectrum Products May Require Careful Review

Full-spectrum CBD products can contain measurable amounts of THC and other cannabinoids. Because the scheduled threshold for certain final products is based on the combined total per retail container, package size and total contents may matter in addition to the amount in one serving.

Retailers should avoid treating a potency result, a “non-intoxicating” description, or a compliant serving size as a substitute for a complete legal review.

Impact on Fiber Producers

Fiber producers could benefit indirectly if cannabinoid hemp becomes less predictable. The amended text expressly defines industrial hemp around specified stalk, fiber, seed, microgreen, research, and other non-cannabinoid uses.

Why Fiber Could Receive More Attention

Fiber hemp is grown primarily for stalk material rather than cannabinoid-rich flowers. Bast fiber and hurd can be processed for textiles, rope, paper, insulation, animal bedding, hempcrete, packaging, nonwovens, and composites.

That makes fiber less dependent on retail cannabinoid rules. Its risks are more closely tied to yield, moisture, retting, equipment, transportation, processing, contracts, and industrial demand.

Fiber Is Not an Automatic Safe Haven

A floral hemp operation cannot switch to fiber simply by planting different seed. Fiber may require different:

• Genetics and seeding rates.
• Planting equipment.
• Field scale.
• Harvest machinery.
• Drying and retting plans.
• Baling and storage systems.
• Transportation relationships.
• Processors and buyers.

Rutgers Cooperative Extension’s hemp fiber production guide emphasizes the importance of suitable production practices, moisture management, retting, baling, and access to processors and markets.

For the existing infrastructure problem, read Why Fiber Hemp Has Struggled to Scale in the United States. For the forward-looking scenario, read Could New Hemp Laws Trigger a Fiber Hemp Boom?.

Possible Industry Responses

The hemp industry is unlikely to respond in one uniform way. Farms will make different decisions based on location, contracts, equipment, capital, crop experience, and tolerance for risk.

1. More Conservative Genetics

Some floral growers may seek genetics with lower and more predictable total-THC expression. Demand may grow for better-supported seed data, regional trials, and written representations from seed suppliers.

2. Reduced Floral Acreage

Farms without dependable buyers may reduce acreage until the market becomes clearer. Smaller plantings may limit exposure but can also increase per-unit production costs.

3. Stronger Contracts Before Planting

Written contracts may become more important. Growers may want terms addressing specifications, sampling, laboratory selection, rejected crops, legal changes, buyer cancellation, delivery, payment, and ownership of stored material.

4. More Testing and Batch Documentation

Farmers, processors, and retailers may require additional pre-harvest tests, official compliance results, post-harvest potency reports, batch tracking, and chain-of-custody documentation.

5. Movement Toward Fiber, Grain, or Seed

Some farmers may explore non-cannabinoid hemp markets. Others may choose established non-hemp crops if the local economics, equipment, insurance, and buyers are more dependable.

6. Regional Industrial-Hemp Development

Fiber and grain growth may occur around existing processors or committed manufacturers. Regional development is more realistic than an immediate national switch because raw fiber and grain markets depend heavily on local logistics.

What Farmers Should Review Before the Next Crop

The safest response is not panic or an unsupported crop switch. It is careful planning based on the best information available.

Genetics and Agronomy

• What total-THC results has this variety produced in the region?
• Are the available trial results independent or supplied only by the seller?
• Does the variety fit the intended buyer and final use?
• What happens if the plants do not match the seller’s representations?

Testing and Compliance

• Which state, tribal, or federal production plan applies?
• What are the official sampling and harvest deadlines?
• Which laboratories may perform required testing?
• How will internal and official test results be documented?
• What is the process if a result exceeds the applicable limit?

Buyer and Contract Risk

• Is there a written purchase agreement before planting?
• Does it define acceptable cannabinoid, moisture, quality, and contamination specifications?
• Who chooses the laboratory and sampling procedure?
• Can the buyer cancel if federal or state law changes?
• Who bears storage, destruction, or resale costs after rejection?
• Is payment secured, guaranteed, or dependent on resale?

Alternative Markets

• Is there another buyer for the same crop?
• Can the crop legally and practically move into another end use?
• Are local fiber, grain, or seed processors actually operating?
• What equipment and transportation would a crop switch require?
• How do projected returns compare with non-hemp crops?

Contract language and legal-change clauses should be reviewed by a qualified attorney familiar with agriculture, hemp, and the relevant jurisdiction.

How the Law Could Change the Hemp Market Structure

The current market has been heavily shaped by floral and cannabinoid products. According to the USDA National Hemp Report for the 2025 production year, open-field floral hemp was valued at $574 million, compared with $13.5 million for open-field fiber hemp.

Fiber hemp had more harvested acreage—21,693 acres compared with 16,880 floral acres—but produced far less reported value. This helps explain why farms were attracted to cannabinoid markets despite their labor and compliance risks.

The scheduled law could create a clearer division between:

• Cannabinoid hemp: Crops and products that satisfy the future definition, product exclusions, FDA requirements, and applicable state rules.
• Industrial hemp: Fiber, qualifying seed uses, grain products, microgreens, research plants, and other specified non-cannabinoid uses.

The USDA Economic Research Service review of industrial hemp viability found that long-term success depends on market development, infrastructure, economic returns, regulation, competition, contracts, and price transparency.

The law may change incentives, but farms still need markets that work.

What This Means for Consumers

Consumers may notice the effects later than farmers. Products could be reformulated, repackaged, discontinued, or replaced as businesses prepare for the scheduled definition.

Shoppers should check current product descriptions, package contents, batch-linked laboratory reports, cannabinoid results, and applicable state rules. A product being offered online does not by itself establish that it is permitted in every jurisdiction.

Green Nursery customers can compare the current CBD flower collection and review available testing through the COA library.

Practical Takeaways

• The federal hemp changes are scheduled to take effect on November 12, 2026, unless the law is amended beforehand.
• The future definition expressly uses total tetrahydrocannabinols, including THCA.
• USDA crop testing already accounts for THCA conversion, but the scheduled law adds broader product exclusions.
• Farmers may feel the impact first because genetics, acreage, contracts, and crop investments are decided before retail demand is known.
• High-THCA flower faces a direct problem under the future total-tetrahydrocannabinol definition.
• CBD flower would still need to satisfy applicable total limits and buyer specifications.
• Processors may change biomass specifications and purchasing contracts.
• Retail decisions can move backward through processors to farms.
• Fiber, grain, and seed may attract more attention, but they require different equipment, infrastructure, and buyers.
• Farmers should review genetics, testing, contracts, alternative markets, and crop budgets before planting.

Frequently Asked Questions

When are the November hemp law changes scheduled to take effect?

The amendments in Section 781 of Public Law 119-37 are scheduled to take effect on November 12, 2026. Congress could amend the law, and agencies may issue additional implementation guidance.

What is the biggest scheduled change for hemp farmers?

The federal hemp definition is scheduled to use total tetrahydrocannabinols, including THCA. Farmers may also face changing demand because the law excludes certain intermediate and final cannabinoid products.

Does USDA already test hemp crops for total THC?

Yes. USDA’s current crop-compliance guidelines use a post-decarboxylation or similarly reliable method that accounts for THCA conversion. The future statutory change goes beyond testing by changing the hemp definition and addressing cannabinoid products.

Will the law affect CBD flower growers?

It could. CBD flower would need to satisfy the applicable total-tetrahydrocannabinol threshold, and buyers may adopt more conservative specifications. The effect will depend on genetics, test results, federal implementation, state law, and market demand.

Could THCA flower be affected?

Yes. The scheduled definition expressly includes THCA. Flower above the future 0.3% total-tetrahydrocannabinol threshold would not meet that federal hemp definition.

What is the scheduled 0.4-milligram finished-product limit?

The amended text excludes certain final hemp-derived cannabinoid products containing greater than 0.4 milligrams combined total per retail container of total tetrahydrocannabinols and covered similar-effect cannabinoids. The threshold applies per container, not per serving.

How could processors affect farmers?

Processors may change the cannabinoid profiles, documentation, test results, and contract terms they require from biomass suppliers. If processors reduce orders, farmers can lose demand before the finished-product rules are visible to consumers.

Could fiber hemp benefit?

Possibly. The scheduled law expressly defines industrial hemp around specified non-cannabinoid uses. However, fiber hemp can only expand where processors, contracts, transportation systems, manufacturers, and buyers are available.

Should farmers switch from flower to fiber?

Not without market research and a dependable buyer. Fiber hemp requires different genetics, production methods, equipment, acreage, harvest systems, transportation, and processing relationships. Farmers should compare complete enterprise budgets and contract terms before switching.

What should consumers look for as hemp laws change?

Consumers should look for clear product descriptions, current batch-linked COAs, accurate package information, reasonable claims, and applicable shipping restrictions. Green Nursery customers can review available COAs and lab reports before ordering.